Phosphodiesterase 1 upregulation in pulmonary arterial hypertension – target for anti-remodeling therapy
R. T. Schermuly, X. Tian, R. Dumitrascu, S. Pullamsetti, G. Kwapiszewska, N. Weissmann, H. Ghofrani, T. Dunkern, H. Tenor, R. Voswinckel, W. Klepetko, R. Paddenberg, W. Kummer, W. Seeger, F. Grimminger (Giessen, Konstanz, Germany; Vienna, Austria)
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. T. Schermuly, X. Tian, R. Dumitrascu, S. Pullamsetti, G. Kwapiszewska, N. Weissmann, H. Ghofrani, T. Dunkern, H. Tenor, R. Voswinckel, W. Klepetko, R. Paddenberg, W. Kummer, W. Seeger, F. Grimminger (Giessen, Konstanz, Germany; Vienna, Austria). Phosphodiesterase 1 upregulation in pulmonary arterial hypertension – target for anti-remodeling therapy. Eur Respir J 2006; 28: Suppl. 50, 987
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: